Atreca, Inc. EV/EBITDA

EV/EBITDA of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/EBITDA growth rates and interactive chart. EV/EBITDA is a ratio that compares a company’s Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation & Amortization (EBITDA). The EV/EBITDA ratio is a valuation metric used to compare the relative value of different businesses. A low EV/EBITDA compared to a stock’s historical average or industry can indicate undervaluation.


Highlights and Quick Summary

Current EV/EBITDA of Atreca, Inc. is 0.05 (as of December 31, 2021)
  • EV/EBITDA for the quarter ending March 31, 2022 was 0.0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly EV/EBITDA decreased by NaN%
  • Annual EV/EBITDA for 2021 was 0.05 (a Infinity% increase from previous year)
  • Annual EV/EBITDA for 2020 was 0.0 (a NaN% decrease from previous year)
  • Annual EV/EBITDA for 2019 was 0.0 (a NaN% decrease from previous year)
Visit stockrow.com/BCEL for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/EBITDA of Atreca, Inc.

Most recent EV/EBITDAof BCEL including historical data for past 10 years.

Interactive Chart of EV/EBITDA of Atreca, Inc.

Atreca, Inc. EV/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.0
2021 0.0 0.0 0.0 0.05
2020 0.0 0.0 0.0 0.0 0.0
2019 0.0 0.0
2018 0.0
2017 0.0

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology